Maxwell Sensors Inc. has span-off Digital Magnetic Beads technology to Applied BioCode, Inc., which was formed to commercialize the multiplex Digital Magnetic Beads for molecular diagnostics and life science applications.  Applied BioCode's 1st product runs 32-plex tests in one microwell.

Maxwell Sensors Inc. is awarded a research grant from National Human Genome Research Institute to study "Automated Tag Library Generation for Sequencing-Based Gene Expression Profiling".

Maxwell Sensors Inc. and Beckman Research Institute of the City of Hope at Duarte, CA are awarded a research grant by National Cancer Institute to develop “Ultra-rare circulation tumor DNA detection with PAP and digital bead technologies”.

NIH awards Maxwell Sensors Inc. $759,000 Phase II grant to further develop “A High-Throughput Pharmacogenetic Profiling Assay for Clinical Use”.

Maxwell Sensors Inc. is selected to present "Digital Magnetic Beads for Multiplexed Assays" at the 40th Annual AACC Oak Ridge Conference: "Breakthrough Technologies for Clinical Diagnostics" on April 17~18, 2008 at San Jose, CA.

US Patent Office recently issued three patents to Maxwell Sensors Inc. One patent for "Photoncounting methods and devices for luminescence analysis" and two CIP patents for "Optical apparatus for treating vulnerable plaque".

Maxwell Sensors was invited to present “Self-contained chemiluminescence bio-disc for ultra sensitive diagnostic at point of care” at the fifth Anniversary Symposium of National Institute of Biomedical Imaging and Bioengineering (NIBIB) of National Institute of Health, changing the world’s healthcare through biomedical technologies at Bethesda, Maryland.

The Regents of the University of California awards Integrated Nano-systems Research Facility (INRF) of the University of California at Irvine and Maxwell Sensors Inc. "UC Discovery Grant" to conduct “Research and Development for LifeChips Manufacturing”.

MSI and East West Analytical Instruments, Inc. of Beijing, China form a joint venture to target Chinese clinical market for cancer, infectious diseases, and other disease diagnostics.

MSI scientists' Technical Article: "Attomole Quantitative Chemiluminescence for Molecular Diagnostics" is published on American Biotechnology Laboratory January 2007 issue. Link to PDF article directly.

Top

US Patent office issued another microfluidic device patent to Maxwell Sensors Inc.: "Self-Contained Microfluidic Biochip and Apparatus".

NSF awards Maxwell Sensors Inc. $500,000 Phase II grant to further develop “Rapid and Automated Differential Gene Expressing Profiling Technology”.

Maxwell Sensors presented “Automated Microfluidic Bio-Disc and Multiplexed Assay for Clinical Applications” at the Biotech workshop hosted by Monte Jade Science & Technology Association and Caltech Entrepreneur Club at California Technology Institute, Pasadena, CA.

US Patent office issued another microfluidic device patent to Maxwell Sensors; this patent will further expand our core technology: Chemiluminescence-based microfluidic biochip patent portfolio.

NIH Awards a research grant to Maxwell Sensors Inc. and City of Hope of Duarte, CA to develop “Highly-multiplexed HLA typing using PAP and digital bead technology”.

NIH Awards $567,000 grant to Maxwell Sensors Inc. and University of California at Irvine, Department of Pathology and Laboratory Medicine  to develop “Microfluidic bio-disc for HIV-1 monitoring”.

Top

"UC Discovery Grant" awards both Integrated Nano-systems Research Facility (INRF) of the University of California at Irvine and Maxwell Sensors Inc. to develop “Zero-power sensing technology”.

Maxwell Sensors Inc. engages with Morrison & Foerster LLP to perform legal service.  Attorney Hillel T. Cohn of Morrison & Foerster LLP will represent MSI in connection with general corporate matters.

Maxwell Sensors Inc. establishes Asia Marketing and Engineering Service Center at Taipei, Taiwan to serve the LuminMax customers. Mr. Philip Huang is appointed to coordinate the seven distributors in Asia and Mid-East area. 

NIH awards Maxwell Sensors Inc. $750,000 grant to develop "All-in-One Biochip for Infectious Disease Screening".

Maxwell Sensors Inc. launches LuminMax-C, a compact attomoles sensitivity luminometer, into market. It is the most sensitive and cost effective microplate luminometer on the market.

Presentation: “MCL disc and platform for cardiac marker tests”, hosted by Medtech Insight at San Francisco, CA.

Technology demonstration: Moving Biosensors to Point-of-Care Cancer Diagnostics, Hosted by National Cancer Institute (NCI), NIH, Rockville MD. “Microfluidic Bio-disc for Point-of-Care Cancer Diagnostics”.

NSF awards Maxwell Sensors Inc. $468,500 grant to develop “ELISA Biosensor for Rapid Bioterrorism Related Agent Diagnosis”.

Top

Maxwell Sensors presented “Automated Microfluidic Bio-Disc for Rapid Biothreat Agent Detection and Diagnosis” at the Detector/Sensor Research & Technology for Homeland and National Security, Hosted by Oakridge National Laboratory.

NSF awards Maxwell Sensors Inc. $100,000 grant to develop “Rapid and Automated Differential Gene Expressing Profiling Technology”.

Presentation: Southern California Biomedical Council - 6th Annual Conference at Wilshire Grand Hotel, Los Angeles, CA.

Integrated Nano-systems Research Facility (INRF), University of California, Irvine and Maxwell Sensors, Inc. have established a research agreement to develop Bio-micro-instrumentation Platform Technology.

Top

The Regents of the University of California awards Integrated Nano-systems Research Facility (INRF) of the University of California at Irvine and Maxwell Sensors Inc. "UC Discovery Grant" to develop “Bio-micro-instrumentation Platform Technology”.

Navy awards Maxwell Sensors Inc. $750,000 grant to develop “A Highly Sensitive Array-based POCT sensor for Respiratory Pathogens”.

NIH awards Maxwell Sensors Inc. $800,000 grant to develop “Chemiluminescence Biochip for Immunoassay”.